Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study

BMJ 2012; 344 doi: (Published 28 March 2012) Cite this as: BMJ 2012;344:e2360

Two errors survived the editing process in this Research article by Gary M Ginsberg and colleagues (BMJ 2012;344:e614, doi:10.1136/bmj.e614). The title of table 4 should be “Model inputs for cost effectiveness analysis of cervical cancer [not colorectal as well] control in….” In the bottom four rows of table 5 the disability weights for colorectal cancer should be: 0.08 [not 0.80] for diagnosis and treatment; 0.08 [not 0.80] for watchful waiting; 0.75 [not 0.25] for metathesis; and 0.81 [not 0.19] for terminal cancer.


Cite this as: BMJ 2012;344:e2360

View Abstract